Allergy Research Foundation, Effenseweg 42, Breda 4838 BB, The Netherlands.
Br J Ophthalmol. 2013 Jul;97(7):820-8. doi: 10.1136/bjophthalmol-2012-302829. Epub 2013 Apr 23.
The allergic reaction taking place in the nasal mucosa can induce a secondary ocular (keratoconjunctival) response of an immediate (SIOR), late (SLOR) or delayed (SDYOR) type in some patients with keratoconjunctivitis (KC).
To investigate the concentration changes of histamine, tryptase, eosinophil-derived neurotoxin (EDN), eosinophil cationic protein (ECP), eosinophilic peroxidase (EPO), leucotrienes (LTB₄, LTC₄, LTE₄), prostaglandins (PGD₂, PGE₂ and PGF₂α), thromboxane B₂ (TXB₂), myeloperoxidase (MPO), interferon-γ (IFN-γ) and interleukins (IL-2, IL-4 and IL-5) in tears during the SIOR, SLOR and SDYOR.
19 SIORs (p<0.001), 28 SLORs (p<0.001) and 10 SDYORs (p<0.05) recorded in 57 KC patients following nasal challenges with allergens (NPT) and 57 phosphate-buffered saline (PBS) control tests were repeated and supplemented with determination of the mediators in tears.
The ocular response types were associated with significant changes (p<0.05) of mediators in tears as follows: (1) SIORs: histamine, tryptase, ECP, LTC₄, PGD₂, PGF₂α, IL-4 and IL-5; (2) SLORs: histamine, ECP, EDN, LTB₄, LTC₄, PGE₂, MPO, IL-4 and IL-5; (3) SDYORs: LTB4, TXB₂, MPO, IFN-γ and IL-2. No significant changes of these factors were measured in tears during the 57 PBS controls (p>0.1).
These results demonstrate a causal involvement of nasal allergy in some KC patients, inducing a secondary keratoconjunctival response of an immediate (SIOR), late (SLOR) or delayed (SDYOR) type, associated with different inflammatory mediator profiles in the tears, suggesting participation of different hypersensitivity mechanisms. These results also emphasise the diagnostic value of nasal challenge with allergen combined with monitoring of ocular response in KC patients, responding insufficiently to the usual ophthalmologic therapy.
在鼻黏膜发生过敏反应时,某些过敏性结膜炎(KC)患者会发生即刻性眼(角结膜)反应(SIOR)、迟发性眼(角结膜)反应(SDYOR)或迟发性眼(角结膜)反应(SLOR)。
研究组织胺、类胰蛋白酶、嗜酸性粒细胞衍生的神经毒素(EDN)、嗜酸性粒细胞阳离子蛋白(ECP)、嗜酸性粒细胞过氧化物酶(EPO)、白三烯(LTB₄、LTC₄、LTE₄)、前列腺素(PGD₂、PGE₂和 PGF₂α)、血栓素 B₂(TXB₂)、髓过氧化物酶(MPO)、干扰素-γ(IFN-γ)和白细胞介素(IL-2、IL-4 和 IL-5)在 SIOR、SLOR 和 SDYOR 期间在泪液中的浓度变化。
对 57 例 KC 患者进行过敏原鼻激发试验(NPT)和 57 例磷酸缓冲盐水(PBS)对照试验,并重复记录 19 例 SIOR(p<0.001)、28 例 SLOR(p<0.001)和 10 例 SDYOR(p<0.05),并补充泪液中介质的测定。
眼部反应类型与泪液中介质的显著变化(p<0.05)有关:(1)SIOR:组织胺、类胰蛋白酶、ECP、LTC₄、PGD₂、PGF₂α、IL-4 和 IL-5;(2)SLOR:组织胺、ECP、EDN、LTB₄、LTC₄、PGE₂、MPO、IL-4 和 IL-5;(3)SDYOR:LTB₄、TXB₂、MPO、IFN-γ 和 IL-2。在 57 例 PBS 对照中,泪液中未测量到这些因子的显著变化(p>0.1)。
这些结果表明,某些 KC 患者的鼻过敏会引起继发的角结膜反应,表现为即刻性(SIOR)、迟发性(SLOR)或迟发性(SDYOR)反应,与泪液中不同的炎症介质谱相关,提示不同的过敏机制参与其中。这些结果还强调了在对常规眼科治疗反应不足的 KC 患者中,通过过敏原鼻激发试验联合监测眼部反应进行诊断的价值。